Kim S K, Ro J Y, Kemp B L, Lee J S, Kwon T J, Fong K M, Sekido Y, Minna J D, Hong W K, Mao L
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Cancer Res. 1997 Feb 1;57(3):400-3.
Deletion at 9p21 is frequent in many tumor types. A candidate tumor suppressor gene, p16INK4a, was mapped to this region and is frequently inactivated by several different mechanisms in many tumor types, including non-small cell lung cancer, but not in small cell lung cancer (SCLC). p16 functions as a cyclin/CDK inhibitor to prevent phosphorylation of pRB. It has been demonstrated that most SCLCs have lost pRB but retained p16, and the inactivation of pRB excludes the inactivation of p16 and vice versa. To determine the potential existence of other tumor suppressor genes on the short arm of chromosome 9 in SCLC, we tested 46 primary SCLCs by microsatellite analysis. We found that more than 89% of the tumors exhibited loss of heterozygosity (LOH) at 9p with three distinct minimal deleted areas. Among those areas, LOH at 9p21 was most frequent (86%), with a peak at a marker 150 kb telomeric to p16INK4a. LOH was also observed in more than 50% of the tumors at two other regions, 9p22 and 9p13. Our data strongly suggest the presence of at least three novel tumor suppressor loci on 9p in SCLC, and further investigations to clone candidate tumor suppressor genes are warranted.
9p21缺失在多种肿瘤类型中很常见。一个候选肿瘤抑制基因p16INK4a被定位到该区域,并且在包括非小细胞肺癌在内的多种肿瘤类型中经常通过几种不同机制失活,但在小细胞肺癌(SCLC)中不会失活。p16作为细胞周期蛋白/细胞周期蛋白依赖性激酶(CDK)抑制剂发挥作用,以防止视网膜母细胞瘤蛋白(pRB)磷酸化。已经证明,大多数小细胞肺癌失去了pRB但保留了p16,并且pRB的失活排除了p16的失活,反之亦然。为了确定小细胞肺癌9号染色体短臂上其他肿瘤抑制基因的潜在存在情况,我们通过微卫星分析检测了46例原发性小细胞肺癌。我们发现,超过89%的肿瘤在9p处表现出杂合性缺失(LOH),有三个不同的最小缺失区域。在这些区域中,9p21处的LOH最为常见(86%),在p16INK4a端粒方向150 kb处的一个标记位点出现峰值。在另外两个区域9p22和9p13,超过50%的肿瘤也观察到了LOH。我们的数据强烈表明,小细胞肺癌9p上至少存在三个新的肿瘤抑制基因座,因此有必要进一步开展研究以克隆候选肿瘤抑制基因。